Theophylline

NDC 46708-025 · Alembic Pharmaceuticals Limited

Generic nameTheophylline

Dosage formTABLET, EXTENDED RELEASE

RouteORAL

Active ingredient(s)THEOPHYLLINE ANHYDROUS

Strength300 mg/1

Pharmacologic classMethylxanthine [EPC], Xanthines [CS]

Marketing categoryANDA

Packages

46708-025-30 — 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-025-30)

46708-025-31 — 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-025-31)

46708-025-71 — 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-025-71)

46708-025-91 — 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-025-91)

FDA lists these products with the same active ingredient.

17856-0038 — Theophylline, 23155-741 — Theophylline, 23155-742 — Theophylline, 27241-272 — Theophylline, 27241-273 — Theophylline, 27808-033 — Theophylline, 31722-077 — Theophylline, 31722-078 — Theophylline, 42291-922 — Theophylline, 46708-026 — Theophylline, 51407-318 — Theophylline, 51407-319 — Theophylline, 52244-100 — theophylline anhydrous, 52244-200 — theophylline anhydrous, 52244-300 — theophylline anhydrous, 52244-400 — theophylline anhydrous, 60219-2045 — theophylline, 60219-2046 — theophylline, 62135-457 — Theophylline, 62135-556 — Theophylline, +22 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.